Your browser doesn't support javascript.
loading
Combination mTOR and SHP2 inhibitor treatment of lymphatic malformation endothelial cells.
Wolter, Jennifer K; Valencia-Sama, Ivette; Osborn, Alex J; Propst, Evan J; Irwin, Meredith S; Papsin, Blake; Wolter, Nikolaus E.
Afiliação
  • Wolter JK; Department of Otolaryngology, Head & Neck Surgery, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Valencia-Sama I; Cell Biology Program, The Hospital for Sick Children, Toronto, Canada.
  • Osborn AJ; Department of Otolaryngology, Head & Neck Surgery, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Propst EJ; Department of Otolaryngology, Head & Neck Surgery, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Irwin MS; Cell Biology Program, The Hospital for Sick Children, Toronto, Canada; Department of Medical Biophysics, University of Toronto, Toronto, Canada; Department of Pediatrics, The Hospital for Sick Children, Toronto, Canada.
  • Papsin B; Department of Otolaryngology, Head & Neck Surgery, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
  • Wolter NE; Department of Otolaryngology, Head & Neck Surgery, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada. Electronic address: nikolaus.wolter@sickkids.ca.
Microvasc Res ; 143: 104397, 2022 09.
Article em En | MEDLINE | ID: mdl-35671835
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfatidilinositol 3-Quinases / Células Endoteliais Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fosfatidilinositol 3-Quinases / Células Endoteliais Idioma: En Ano de publicação: 2022 Tipo de documento: Article